Showing results (2151-2160 of 3,662) with videos related to

Sort By:
Pageof 367
Breast (Edinburgh, Scotland)|April 8, 2025
Paclitaxel-related type I Kounis Syndrome in a very young patient with HER2-positive breast cancer and the role of genomics to disentangle a complex therapeutic scenario: a case report and narrative reviewJavier Muñoz, Sabrina Nucera, Nuria Rubira Garcia, et al.
Breast (Edinburgh, Scotland)|December 19, 2024
Survival feature and trend of female breast cancer: A comprehensive review of survival analysis from cancer registration dataDan-Dan Tang, Zhuo-Jun Ye, Wan-Wan Liu, et al.
Breast (Edinburgh, Scotland)|December 1, 2024
Safety profile of sacituzumab govitecan in patients with breast cancer: A systematic review and meta-analysisMaria Inez Dacoregio, Isabella Michelon, Caio Ernesto do Rego Castro, et al.
Breast (Edinburgh, Scotland)|December 3, 2024
Adipocyte heterogeneity and tumor infiltration of adipose tissue in patients with metastatic breast cancerHava Izci, Gitte Zels, Anirudh Pabba, et al.
Breast (Edinburgh, Scotland)|December 15, 2024
General obesity, abdominal obesity, and the risk of cardiovascular disease including stroke in 5-year breast cancer survivorsJi Soo Kim, Jihun Song, Seulggie Choi, et al.
Breast (Edinburgh, Scotland)|December 24, 2024
Cyclin-dependent kinase 4 and 6 inhibitors (CDK4/6i): Mechanisms of resistance and where to find themL Foffano, L Cucciniello, E Nicolò, et al.
Breast (Edinburgh, Scotland)|November 9, 2024
Olaparib monotherapy in advanced triple-negative breast cancer patients with homologous recombination deficiency and without germline mutations in BRCA1/2: The NOBROLA phase 2 studyAlfonso Cortés, Elena López-Miranda, Adela Fernández-Ortega, et al.
Breast (Edinburgh, Scotland)|October 16, 2024
The efficacy and safety of CDK4/6 inhibitors combined with endocrine therapy versus endocrine therapy alone in the adjuvant treatment of patients with high-risk invasive HR+/HER2-early breast cancer: A comprehensive updated meta-analysis of randomized clinical trialsMerve Keskinkilic, Mehmet Emin Arayici, Yasemin Basbinar, et al.
Breast (Edinburgh, Scotland)|October 15, 2024
Could macrocytosis predict survival In advanced breast cancer patients that were treated with CDK 4-6 inhibitors?Ilkay Gültürk, Rumeysa Colak, Caner Kapar, et al.
Breast (Edinburgh, Scotland)|September 26, 2024
The impact of advanced oncoplastic surgery on breast-conserving surgery rates: A retrospective cohort study of 3,875 breast cancer procedures at a tertiary referral centreAngus Reid, Robert Thomas, Andrew Pieri, et al.
Pageof 367